Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farook Al-Azzawi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Climacteric : the Journal of the International Menopause Society|October 30, 2013
Measuring vulvovaginal symptoms in postmenopausal womenFarook Al-Azzawi
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 26, 2008
Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonatesFarook Al-Azzawi
Maturitas|June 30, 2004
The turbulent seas of women's health--who is the beneficiary?Farook Al-Azzawi
Treatments in Endocrinology|August 28, 2004
17 beta-estradiol/levonorgestrel transdermal system. A viewpoint by Farook al-AzzawiFarook al-Azzawi
Women'S Health (London, England)|May 4, 2013
The clinical choice between estrogen and bisphosphonates to prevent bone loss: are women being misled?Farook Al-Azzawi
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Use of the levonorgestrel intrauterine system in postmenopauseFarook Al-Azzawi
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Levonorgestrel and breast cancer risk - clarifiedFarook Al-Azzawi
Women'S Health (London, England)|October 7, 2009
Current state of hormone replacement therapy: the case for using trimegestoneMay Wahab, Farook Al-Azzawi
Women'S Health (London, England)|December 17, 2011
A modern approach to postmenopausal HRT: trading bleeding with safetyFarook Al-Azzawi, May Wahab
Women'S Health (London, England)|August 26, 2009
Report on the 8th European Congress on MenopauseElizabeth Eglinton, Farook Al-Azzawi
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Climacteric : the Journal of the International Menopause Society|October 30, 2013
Measuring vulvovaginal symptoms in postmenopausal womenFarook Al-Azzawi
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 26, 2008
Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonatesFarook Al-Azzawi
Maturitas|June 30, 2004
The turbulent seas of women's health--who is the beneficiary?Farook Al-Azzawi
Treatments in Endocrinology|August 28, 2004
17 beta-estradiol/levonorgestrel transdermal system. A viewpoint by Farook al-AzzawiFarook al-Azzawi
Women'S Health (London, England)|May 4, 2013
The clinical choice between estrogen and bisphosphonates to prevent bone loss: are women being misled?Farook Al-Azzawi
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Use of the levonorgestrel intrauterine system in postmenopauseFarook Al-Azzawi
Climacteric : the Journal of the International Menopause Society|May 14, 2015
Levonorgestrel and breast cancer risk - clarifiedFarook Al-Azzawi
Women'S Health (London, England)|October 7, 2009
Current state of hormone replacement therapy: the case for using trimegestoneMay Wahab, Farook Al-Azzawi
Women'S Health (London, England)|December 17, 2011
A modern approach to postmenopausal HRT: trading bleeding with safetyFarook Al-Azzawi, May Wahab
Women'S Health (London, England)|August 26, 2009
Report on the 8th European Congress on MenopauseElizabeth Eglinton, Farook Al-Azzawi
Pageof 4